ENTA
ENANTA PHARMACEUTICALS INCData as of 2026 Q2 (06-30) · 13F snapshot
Summary
ENANTA PHARMACEUTICALS INC (ENTA) is held as common stock by 3 tracked hedge-fund managers, with a combined reported value of ~$18.26M; the largest are Izzy Englander, Renaissance Technologies, Ken Griffin. 1 tracked manager also disclosed PUT or CALL positions, reported separately below. This quarter: 3 trimmed, 1 closed. 1 public STOCK Act / OGE trade disclosures are on record. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.
Attention · LowThis quarter · Cooling
Common-stock holders31 also report options
Congress trades1
Price$12.61vs quarter-end-13.48%
Sectors0
This quarter's moves
Top holderNew0
Added0
Trimmed / sold4
Izzy EnglanderCommon-stock positions
PUT and CALL disclosures are excluded from these holder counts and values.
| Investor | Value | % of portfolio | Action |
|---|
PUT / CALL disclosures
Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.
Value $382.0K— of portfolio26,2002026 Q2
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinCALL | $382.0K | — | — |
Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.